 |
|
| Blog results | Results 1 - 10 of about 3,742 for capecitabine oral. (0.18 seconds) |
| Sorted by relevance Sort by date |
| 19 Nov 2009 Patients also receive conatumumab IV over 30-60 minutes on days 1, 15, and 29 and oral capecitabine twice daily, 5 days a week, for 5½ weeks. - Maintenance therapy: Beginning 28-56 days after completion of chemoradiotherapy, ... Clinical Trials Updates During the Last 7 Days - http://clinicaltrialsfeeds.org/clinical-trials/r... [ More results from Clinical Trials Updates During the Last 7 Days ] |
| 24 Jul 2009 by Dr. Charles Balch The results in over 600 elderly patients showed that standard intravenous chemotherapy gave better survival results than oral capecitabine alone. Dr Muss discusses the current state of using this drug in breast cancer patients. ... My Cancer Advisor - http://mycanceradvisor.com/ |
| 4 Dec 2009 by mjames Among breast and colorectal cancer patients treated with the oral chemotherapy drug Xeloda® (capecitabine), symptom management was better among patients who received home care nursing than among patients who received standard care. CancerConsultants - http://www.cancerconsultants.com/ |
| 2 Dec 2009 by admin Home care nursing (HCN) improves the management of symptoms in breast and colorectal cancer patients who take the oral chemotherapy drug capecitabine, according to a study published online November 16 in the Journal of Clinical Oncology ... Tobacco Facts. - http://www.tobacco-facts.net/ - References |
| 12 Nov 2009 by Dr. NICK November 10, 2009 — Adding the oral drug capecitabine (Xeloda) to standard chemotherapy regimens appears to reduce the risk for recurrence in early breast cancer. Finnish researchers report that for patients with moderate- to high-risk ... CANCER AND IMPORTANT MEDICAL NEWS - http://cancerology.blogspot.com/ |
| 28 Aug 2009 by Domingo, E., Lorvidhaya, V., de los Reyes,... Capecitabine and radiotherapy show preclinical synergy and clinical activity. The activity, tolerability, and oral administration of capecitabine make it an attractive adjunctive therapy. Methods. In this phase II study, patients with ... The Oncologist current issue - http://theoncologist.alphamedpress.org/ |
| 6 Jun 2009 by niclamra1958 capecitabine - oral. (cap-eh-sit-uh-bean). common brand name(s): xeloda. warning: capecitabine may interact with “blood thinners” (anticoagulants such as warfarin or phenprocoumon) and cause serious bleeding episodes; rarely, ... Nicholas Lambeth - http://niclamra1958.thevirtualunderground.net/ |
| 23 Sep 2009 The study evaluated Nexavar in combination with the oral chemotherapeutic, capecitabine, in patients with locally advanced or metastatic HER-2 negative breast cancer. Overall, treatment with Nexavar plus capecitabine showed an ... PharmaNews.eu - http://www.pharmanews.eu/component/content/frontpage [ More results from PharmaNews.eu ] |
| 20 Oct 2009 by nelm@gstt.nhs.uk Keyword(s), Administration-Oral; Antineoplastics; Imatinib; Capecitabine; Monitoring; Patient Compliance; Pharmacokinetics; Predictive Models;. Printer Friendly Version. Version 0.2 -- Released 15.11.02, Terms & Conditions - Information ... Pharm-line - http://www.pharm-line.nhs.uk/ |
| 8 Oct 2007 The oral chemotherapy drug Xeloda (capecitabine) offers fewer side-effects and less time in hospital – and the trial has shown that patients given the drug were at least as likely to be alive and free of their disease as those on ... University of Leeds press releases | RSS feed - http://reporter.leeds.ac.uk/press_releases/ - References |
Stay up to date on these results:
| Google Home - About Google Blog Search Beta - Information for Blog Authors |
